Pia Abel Zur Wiesch

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Klebsiella Pneumoniae

Randomized Controlled Trial

Top Venues

PLoS computational biology

Cellular and molecular life sciences : CMLS

ERJ open research

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Antal Martinecz, Martin J Boeree, Andreas H Diacon, Rodney Dawson, Colin Hemez, Rob E Aarnoutse, Pia Abel Zur Wiesch
High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistance. PLoS computational biology 19 (4) (2023)
Viacheslav N Kachalov, Huyen Nguyen, Suraj Balakrishna, Luisa Salazar-Vizcaya, Rami Sommerstein, Stefan P Kuster, Anthony Hauser, Pia Abel Zur Wiesch, Eili Y Klein, Roger D Kouyos
Identifying the drivers of multidrug-resistant Klebsiella pneumoniae at a European level. PLoS computational biology 17 (1) (2021)
Fabrizio Clarelli, Adam C Palmer, Bhupender Singh, Merete Storflor, Silje Lauksund, Ted Cohen, Sören Abel, Pia Abel Zur Wiesch
Drug-target binding quantitatively predicts optimal antibiotic dose levels in quinolones. PLoS computational biology 16 (8) (2020)
Helen Ruth Stagg, Mary Flook, Antal Martinecz, Karina Kielmann, Pia Abel Zur Wiesch, Aaron S Karat, Marc Caeroos Isaac Lipman, Derek J Sloan, Elizabeth F Walker, Katherine L Fielding
All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era. ERJ open research 6 (4) (2020)
Antal Martinecz, Fabrizio Clarelli, Sören Abel, Pia Abel Zur Wiesch
Reaction Kinetic Models of Antibiotic Heteroresistance. International journal of molecular sciences 20 (16) (2019)
Fabrizio Clarelli, Jingyi Liang, Antal Martinecz, Ines Heiland, Pia Abel Zur Wiesch
Multi-scale modeling of drug binding kinetics to predict drug efficacy. Cellular and molecular life sciences : CMLS 77 (3) (2019)